SHARKS TRADING LTD

Company number 13128192 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

SHARKS TRADING LTD - Analysis Report

Company Number: 13128192

Analysis Date: 2025-07-20 12:52 UTC

Financial Health Assessment of SHARKS TRADING LTD


1. Financial Health Score: D

Explanation:
The company’s financial health shows significant signs of distress in the latest year. A negative net asset position and net current liabilities indicate liquidity challenges. Although it was healthier in prior years, the sharp deterioration in the most recent financial year suggests urgent attention is needed to restore stability.


2. Key Vital Signs (Core Financial Metrics)

Metric 2024 (£) 2023 (£) Interpretation
Current Assets 73 5,163 Drastic reduction in liquid resources; very limited ability to cover short-term obligations.
Current Liabilities 291 3,962 Current liabilities have decreased but still exceed current assets in 2024, causing liquidity strain.
Net Current Assets -218 1,201 Shift from positive working capital to negative, indicating a liquidity crunch ("symptom of distress").
Net Assets (Shareholders Funds) -818 1 Net liabilities in 2024 show erosion of equity capital, signaling accumulated losses or write-downs.
Share Capital 1 1 Minimal share capital indicates limited financial buffer.
Number of Employees 1 1 Small scale operation; limited human resource commitments.

3. Diagnosis (What the Financial Data Reveals)

  • Liquidity Crisis: The company’s "healthy cash flow" is compromised as evidenced by current liabilities surpassing current assets, resulting in negative working capital. This is akin to a patient whose vital signs show dehydration and weakness — the business lacks sufficient liquid assets to meet immediate demands.

  • Equity Erosion: The negative net assets position indicates the company’s obligations exceed its total assets. This is a "symptom" of either operational losses, asset impairments, or lack of new capital injection, leading to insolvency risk if not addressed.

  • Declining Asset Base: Current assets have dropped from £5,163 in 2023 to £73 in 2024, a severe contraction suggesting either asset sales, write-offs, or poor cash management.

  • Scale and Risk: As a micro-entity with only one employee and nominal share capital, the company has minimal financial cushioning against shocks, making it vulnerable to market or operational difficulties.

  • No Signs of Formal Distress Proceedings: Despite the financial strain, the company remains active and not in liquidation or administration, which gives a window for remedial actions.


4. Recommendations (Actions to Improve Financial Wellness)

  • Improve Liquidity: Immediate focus should be on improving cash reserves and managing payables. This could involve renegotiating payment terms with creditors or accelerating receivables collection if applicable.

  • Capital Injection: Consider raising additional equity capital to restore positive net assets and provide a buffer for operations. This could be through shareholder loans or new investment.

  • Cost Control: Review and reduce overheads and non-essential expenditures to conserve cash flow, analogous to stabilizing a patient by reducing stressors.

  • Business Model Review: Given the significant drop in current assets and negative equity, evaluate operational efficiency and market strategy to identify root causes of financial deterioration.

  • Financial Monitoring: Implement stronger financial controls and regular reviews of cash flow forecasts to detect early symptoms of distress and respond proactively.

  • Professional Advice: Engage with financial or insolvency advisers early to explore restructuring options and avoid escalation to formal insolvency.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.